Please login to the form below

Not currently logged in
Email:
Password:

Takeda promotes Giles Platford

Appoints him head of commercial operations, emerging markets

Takeda Giles PlatfordTakeda Pharmaceuticals has appointed Giles Platford head of commercial operations, emerging markets with effect from 1 April.  

Platford, who will report to chief operating officer Christopher Weber in his new role, joined Takeda in 2009 and, pre-promotion, was head of the Middle East, Turkey, Africa (META) region.  

Prior to this he was general manager of Takeda Brazil, leading the acquisition of Multilab, a mid-sized company focused on branded generics and over-the-counter (OTC) products. The acquisition made Takeda one of the top 10 pharmaceutical groups in Brazil.   

Before joining Takeda, Platford spent eight years in the pharmaceutical industry in Asia Pacific, in various business development, commercial and general management roles.  

In his new role, Platford will be responsible for leading the continued expansion of Takeda's commercial activities in the META region, which comprises Russia-CIS, Latin America, Middle East/Africa and South Asia.  

“Emerging markets are a key growth driver as we continue to launch new products and expand our geographic footprint. Each market has its own features however, so Takeda has adopted a tailored 'market-specific' portfolio approach,” Platford told PMLiVE.   

“Takeda has one of the richest pipelines in the pharmaceutical industry today, and I am looking forward to further diversifying our offering of medicines to address the medical needs of patients across emerging markets.”

20th March 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics